{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:15:23Z","timestamp":1792095323776,"version":"4.4.0"},"reference-count":43,"publisher":"Society of Nuclear Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.2967\/jnumed.122.265149","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T14:30:33Z","timestamp":1682692233000},"page":"1087-1092","source":"Crossref","is-referenced-by-count":21,"title":["Hybrid<sup>18<\/sup>F-Fluoroethyltyrosine PET and MRI with Perfusion to Distinguish Disease Progression from Treatment-Related Change in Malignant Brain Tumors: The Quest to Beat the Toughest Cases"],"prefix":"10.2967","volume":"64","author":[{"given":"Nathaniel J.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan K.","family":"Deaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Territo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Graner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Gauger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Schulte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary D.","family":"Hutchins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Veronesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2023,4,28]]},"reference":[{"key":"2023063006250750000_64.7.1087.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21693"},{"key":"2023063006250750000_64.7.1087.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.16669"},{"key":"2023063006250750000_64.7.1087.3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.hoc.2021.08.004","article-title":"Central nervous system metastases","volume":"36","author":"Nieblas-Bedolla","year":"2022","journal-title":"Hematol Oncol Clin North Am."},{"key":"2023063006250750000_64.7.1087.4","first-page":"27","volume-title":"Handbook of Clinical Neurology.","volume":"149","author":"Ostrom","year":"2018"},{"key":"2023063006250750000_64.7.1087.5","doi-asserted-by":"crossref","first-page":"8874078","DOI":"10.1155\/2021\/8874078","article-title":"Comparison of amino acid PET to advanced and emerging MRI techniques for neurooncology imaging: a systematic review of the recent studies","volume":"2021","author":"Stopa","year":"2021","journal-title":"Mol Imaging."},{"key":"2023063006250750000_64.7.1087.6","first-page":"214","article-title":"Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendroglimoas","volume":"25","author":"Lev","year":"2004","journal-title":"Am J Neuroradiol."},{"key":"2023063006250750000_64.7.1087.7","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S"},{"key":"2023063006250750000_64.7.1087.8","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1002\/jmri.26518","article-title":"Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trials","volume":"49","author":"Shukla-Dave","year":"2019","journal-title":"J Magn Reson Imaging."},{"key":"2023063006250750000_64.7.1087.9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.18383\/j.tom.2020.00012","article-title":"Evaluating the use of rCBV as a tumor grade and treatment response classifier across NCI quantitative imaging network sites: part II of the DSC-MRI digital reference object (DRO) challenge","volume":"6","author":"Bell","year":"2020","journal-title":"Tomography."},{"key":"2023063006250750000_64.7.1087.10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000023766"},{"key":"2023063006250750000_64.7.1087.11","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/now148"},{"key":"2023063006250750000_64.7.1087.12","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/now058"},{"key":"2023063006250750000_64.7.1087.13","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/neuonc\/noz003","article-title":"PET imaging in patients with brain metastasis: report of the RANO\/PET group","volume":"21","author":"Galldiks","year":"2019","journal-title":"Neuro Oncol."},{"key":"2023063006250750000_64.7.1087.14","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-018-4207-9"},{"key":"2023063006250750000_64.7.1087.15","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.103325"},{"key":"2023063006250750000_64.7.1087.16","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/now149"},{"key":"2023063006250750000_64.7.1087.17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.233809"},{"key":"2023063006250750000_64.7.1087.18","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1007\/s00259-022-05917-3","article-title":"Diagnostic yield of simultaneous dynamic contrast-enhanced magnetic resonance perfusion measurements and [18F]FET PET in patients with suspected recurrent anaplastic astrocytoma and glioblastoma","volume":"49","author":"Henriksen","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2023063006250750000_64.7.1087.19","doi-asserted-by":"publisher","DOI":"10.4103\/neuroindia.NI_101_16"},{"key":"2023063006250750000_64.7.1087.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2018.04.003"},{"key":"2023063006250750000_64.7.1087.21","doi-asserted-by":"publisher","DOI":"10.1002\/mrm.1910140211"},{"key":"2023063006250750000_64.7.1087.22","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-004-1590-1"},{"key":"2023063006250750000_64.7.1087.23","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-016-1545-1"},{"key":"2023063006250750000_64.7.1087.24","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab106"},{"key":"2023063006250750000_64.7.1087.25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochem Med (Zagreb)."},{"key":"2023063006250750000_64.7.1087.26","doi-asserted-by":"publisher","DOI":"10.1037\/0033-2909.86.2.420"},{"key":"2023063006250750000_64.7.1087.27","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3"},{"key":"2023063006250750000_64.7.1087.28","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/26.4.404"},{"key":"2023063006250750000_64.7.1087.29","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.143.1.7063747"},{"key":"2023063006250750000_64.7.1087.30","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.148.3.6878708"},{"key":"2023063006250750000_64.7.1087.31","doi-asserted-by":"publisher","DOI":"10.1093\/biostatistics\/kxj037"},{"key":"2023063006250750000_64.7.1087.32","doi-asserted-by":"publisher","DOI":"10.1098\/rsta.2009.0127"},{"key":"2023063006250750000_64.7.1087.33","first-page":"vdac027","article-title":"Diagnostic performance of DSC perfusion MRI to distinguish tumor progression and treatment-related changes: a systematic review and meta-analysis","volume":"4","author":"Fu","year":"2022","journal-title":"Neurooncol Adv."},{"key":"2023063006250750000_64.7.1087.34","doi-asserted-by":"crossref","first-page":"13258","DOI":"10.1038\/s41598-022-16726-x","article-title":"Discriminators of pseudoprogression and true progression in high-grade gliomas: a systematic review and meta-analysis","volume":"12","author":"Taylor","year":"2022","journal-title":"Sci Rep."},{"key":"2023063006250750000_64.7.1087.35","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2886-4"},{"key":"2023063006250750000_64.7.1087.36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11912-021-01020-2","article-title":"Advanced imaging techniques for neuro-oncologic tumor diagnosis, with an emphasis on PET-MRI imaging of malignant brain tumors","volume":"23","author":"Overcast","year":"2021","journal-title":"Curr Oncol Rep."},{"key":"2023063006250750000_64.7.1087.37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/08465371211013568","article-title":"Qualitative assessment of advanced MRI in post-treatment high grade gliomas follow up: do we agree?","volume":"73","author":"Zakhari","year":"2022","journal-title":"Can Assoc Radiol J."},{"key":"2023063006250750000_64.7.1087.38","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-020-05114-0"},{"key":"2023063006250750000_64.7.1087.39","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262051"},{"key":"2023063006250750000_64.7.1087.40","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1097\/RLU.0000000000004167","article-title":"Glioblastoma recurrence versus radiotherapy injury: combined model of diffusion kurtosis imaging and 11C-MET using PET\/MRI may increase accuracy of differentiation","volume":"47","author":"Dang","year":"2022","journal-title":"Clin Nucl Med."},{"key":"2023063006250750000_64.7.1087.41","first-page":"vdab044","article-title":"Combined 18F-FET PET and diffusion kurtosis MRI in posttreatment glioblastoma: differentiation of true progression from treatment-related changes","volume":"3","author":"D\u2019Amore","year":"2021","journal-title":"Neurooncol Adv."},{"key":"2023063006250750000_64.7.1087.42","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05427-8"},{"key":"2023063006250750000_64.7.1087.43","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.3390\/cancers14143336","article-title":"Two decades of brain tumour imaging with O-(2-[18F]fluoroethyl)-L-tyrosine PET: the Forschungszentrum J\u00fclich experience","volume":"14","author":"Heinzel","year":"2022","journal-title":"Cancers (Basel)."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.122.265149","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T13:30:20Z","timestamp":1688131820000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.122.265149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":43,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,6,30]]},"published-print":{"date-parts":[[2023,7]]}},"alternative-id":["10.2967\/jnumed.122.265149"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.122.265149","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,28]]}}}